The Vaccine Research Group sits under the Department of Infectious Diseases, at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and The University of Melbourne. This group is led by Professor Michelle Giles, an adult infectious diseases physician and clinician scientist with over 20 years of research experience.
Drawing on three decades of clinical trials experience, we conduct vaccine and immunisation research to explore the effectiveness, antibody responses and safety of new vaccines in standard or novel schedules. The unit has extensive experience in both industry-sponsored and investigator-initiated vaccine clinical trials. Vaccines evaluated have included GMOs, live-attenuated intranasal vaccines, as well as oral and conventional vaccines.
Previously the unit conducted clinical research throughout the life cycle from pregnancy, neonates, infancy, childhood, adolescence, and into adults. Under the leadership of our new director, the Vaccine Research Group is now focusing on all adult populations including pregnant people, older adults, healthy adults and vulnerable adult populations.
